spiroplatin

Spiroplatin is a second generation metallodrug and analgue for cisplatin, developed for cancer therapy. Spiroplatin induces DNA cross-links, thereby inhibiting DNA replication and RNA and protein synthesis. Similar to other platinum compounds, this agent has been shown to be mutagenic and carcinogenic.

 

IUPAC name: aqua-1,1-bis(aminomethyl)-cyclohexanesulfatoplatinum(II)